These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18761421)

  • 41. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.
    Niu J; Kolattukudy PE
    Clin Sci (Lond); 2009 Jul; 117(3):95-109. PubMed ID: 19566488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin II enhances the increase in monocyte chemoattractant protein-1 production induced by tumor necrosis factor-{alpha} from 3T3-L1 preadipocytes.
    Asamizu S; Urakaze M; Kobashi C; Ishiki M; Norel Din AK; Fujisaka S; Kanatani Y; Bukahari A; Senda S; Suzuki H; Yamazaki Y; Iwata M; Usui I; Yamazaki K; Ogawa H; Kobayashi M; Tobe K
    J Endocrinol; 2009 Aug; 202(2):199-205. PubMed ID: 19429670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice.
    Kulkarni O; Eulberg D; Selve N; Zöllner S; Allam R; Pawar RD; Pfeiffer S; Segerer S; Klussmann S; Anders HJ
    J Pharmacol Exp Ther; 2009 Feb; 328(2):371-7. PubMed ID: 18997060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation.
    Zahner G; Schaper M; Panzer U; Kluger M; Stahl RA; Thaiss F; Schneider A
    Biochem J; 2009 Aug; 422(3):563-70. PubMed ID: 19570035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monocyte chemotactic protein-1 (MCP-1), its receptor, and macrophages in the perifollicular stroma during the human ovulatory process.
    Dahm-Kähler P; Ghahremani M; Lind AK; Sundfeldt K; Brännström M
    Fertil Steril; 2009 Jan; 91(1):231-9. PubMed ID: 18829011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The combination of polymorphisms within MCP-1 and IL-1beta associated with ulcerative colitis.
    Li KS; Wang BY; Liu SY; Yao SP; Guo L; Mao DW
    Int J Immunogenet; 2009 Jun; 36(3):135-9. PubMed ID: 19392835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monocyte chemoattractant chemokines in cystic fibrosis.
    Rao S; Wright AK; Montiero W; Ziegler-Heitbrock L; Grigg J
    J Cyst Fibros; 2009 Mar; 8(2):97-103. PubMed ID: 19000946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis.
    Rafei M; Berchiche YA; Birman E; Boivin MN; Young YK; Wu JH; Heveker N; Galipeau J
    J Immunol; 2009 Aug; 183(3):1759-66. PubMed ID: 19592643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.
    Buraczynska M; Bednarek-Skublewska A; Buraczynska K; Ksiazek A
    Cytokine; 2008 Dec; 44(3):361-5. PubMed ID: 19014891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monocyte chemoattractant protein-1 in dogs affected with neoplasia or inflammation.
    Ishioka K; Suzuki Y; Tajima K; Ohtaki S; Miyabe M; Takasaki M; Mori A; Momota Y; Azakami D; Sako T
    J Vet Med Sci; 2013 Feb; 75(2):173-7. PubMed ID: 22986270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular basis of lateral force spectroscopy nano-diagnostics: computational unbinding of autism related chemokine MCP-1 from IgG antibody.
    Gogolinska A; Nowak W
    J Mol Model; 2013 Nov; 19(11):4773-80. PubMed ID: 24061853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monocyte chemoattractant protein-1 and hypertension: An overview.
    Cortez A; Muxfeldt E
    Hipertens Riesgo Vasc; 2022; 39(1):14-23. PubMed ID: 34969653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of storage conditions on the stability of recombinant human MCP-1/CCL2.
    Leemasawatdigul K; Gappa-Fahlenkamp H
    Biologicals; 2011 Jan; 39(1):29-32. PubMed ID: 20965747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of polymers and nanoparticles bearing polystyrene sulfonate brushes for chemokine binding.
    Isahak N; Sanchez J; Perrier S; Stone MJ; Payne RJ
    Org Biomol Chem; 2016 Jun; 14(24):5652-8. PubMed ID: 27031327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monocyte chemoattractant protein-1.
    Gu L; Tseng SC; Rollins BJ
    Chem Immunol; 1999; 72():7-29. PubMed ID: 10550927
    [No Abstract]   [Full Text] [Related]  

  • 56. Monocyte chemoattractant protein-1: a key mediator of angiotensin II-induced target organ damage in hypertensive heart disease?
    Zhuo JL
    J Hypertens; 2004 Mar; 22(3):451-4. PubMed ID: 15076146
    [No Abstract]   [Full Text] [Related]  

  • 57. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions.
    Lubkowski J; Bujacz G; Boqué L; Domaille PJ; Handel TM; Wlodawer A
    Nat Struct Biol; 1997 Jan; 4(1):64-9. PubMed ID: 8989326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The chemokine (C-C motif) ligand 2 in neuroinflammation and neurodegeneration.
    Madrigal JL; Caso JR
    Adv Exp Med Biol; 2014; 824():209-19. PubMed ID: 25039002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Level of Monocyte Chemoattractant Protein-1 May Be Affected by Several Factors.
    Gulgun M
    Med Princ Pract; 2018; 27(4):400. PubMed ID: 29779021
    [No Abstract]   [Full Text] [Related]  

  • 60. A New Biomarker in Atrial Fibrillation: Monocyte Chemoattractant Protein-1-Induced Protein.
    Savelieva I; Camm AJ
    Cardiology; 2019; 144(3-4):122-124. PubMed ID: 31715611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.